Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popescu, G
Right arrow Articles by Elliott, M W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popescu, G
Right arrow Articles by Elliott, M W
Thorax 2001;56:727-733 ( September )

Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use

G Popescua, M Lathama, V Allgarb, M W Elliotta

a Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF, UK, b Department of Medical Statistics

Correspondence to: Dr M W Elliott mark.elliott{at}gw.sjsuh.northy.nhs.uk

Received 15 May 2000; Returned to authors 15 August 2000; Revised version received 18 May 2001; Accepted for publication 4 June 2001

BACKGROUND---The sleep apnoea/hypopnoea syndrome (SAHS) is common and treatment with continuous positive airway pressure (CPAP) is effective. However, not all patients can cope with the demands of using mask positive pressure. Compliance can be improved with an intensive educational programme and patient support, but this is not practical in most centres given the large numbers of patients coming forward for treatment. Several studies have evaluated correlations between various parameters at diagnosis in order to anticipate patients' behaviour and to avoid the social and health implications of undertreated SAHS. We have evaluated the use of additional data derived during a 2 week home CPAP trial to identify factors associated with longer term use of CPAP and compliance.
METHODS---Following a diagnostic study, 209 patients were offered a CPAP machine for a 2 week home trial. After completing the trial, patients were reassessed and scored their overall satisfaction with CPAP treatment on a five point scale ranging from "much worse" to "much better" and an Epworth score relating to the loan period. Machine run time was recorded from the integral clock. These data were added to those available at diagnosis to construct models indicative of continuing CPAP and average nightly use at 1 year.
RESULTS---209 patients were offered the 2 week loan at least a year before June 1999 (90.9% men, mean (SD) age 51.0 (10.6) years, body mass index (BMI) 34.6 (7.7) kg/m2, Epworth score 15 (IQR 11-18), apnoea/hypopnoea index (AHI) 38.1 (22.9) events/h). 153 patients (73.2%) opted to continue CPAP and 56 declined. One year later data were available for 187 patients; 128 (68.5% on an intention to treat analysis) continued to use the machine with a mean use of 5.0 (2.4) hours/night. A logistic regression model indicated that mean CPAP use during the loan period and the overall satisfaction score accurately defined continuing CPAP and "satisfactory" CPAP use at 1 year. For patients with low machine use and no symptomatic improvement during the loan period, the addition of baseline AHI, baseline Epworth score, and the Epworth score at the end of the loan to the equation identifying factors associated with "satisfactory" CPAP use (mean >2 hours/night) improved the value of the model.
CONCLUSION---Data derived from a 2 week CPAP trial are useful in identifying patients who will comply with CPAP treatment to 1 year. It can be used to identify patients with significant symptomatic disease who will struggle with CPAP and may benefit from additional education and support. High mean hourly use and a high degree of overall satisfaction during the loan period identified patients likely to use CPAP and be compliant with it at 1 year.


Keywords: sleep apnoea/hypopnoea syndrome; continuous positive airway pressure; home treatment; compliance


© 2001 by Thorax



This article has been cited by other articles:


Home page
Clinical Case StudiesHome page
E. M. Wickwire Jr, J. A. Schumacher, A. C. Richert Jr, A. Sinan Baran, and H. P. Roffwarg
Combined Insomnia and Poor CPAP Compliance: A Case Study and Discussion
Clinical Case Studies, August 1, 2008; 7(4): 267 - 286.
[Abstract] [PDF]


Home page
Proc Am Thorac SocHome page
T. E. Weaver and R. R. Grunstein
Adherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective Treatment
Proceedings of the ATS, February 15, 2008; 5(2): 173 - 178.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. C. Uong, M. Epperson, S. A. Bathon, and D. B. Jeffe
Adherence to Nasal Positive Airway Pressure Therapy Among School-aged Children and Adolescents With Obstructive Sleep Apnea Syndrome
Pediatrics, November 1, 2007; 120(5): e1203 - e1211.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Senn, T. Brack, E. W. Russi, and K. E. Bloch
A Continuous Positive Airway Pressure Trial as a Novel Approach to the Diagnosis of the Obstructive Sleep Apnea Syndrome
Chest, January 1, 2006; 129(1): 67 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Duong, L. Jayaram, D. Camfferman, P. Catcheside, I. Mykytyn, and R. D. McEvoy
Use of heated humidification during nasal CPAP titration in obstructive sleep apnoea syndrome
Eur. Respir. J., October 1, 2005; 26(4): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Bachour and P. Maasilta
Mouth Breathing Compromises Adherence to Nasal Continuous Positive Airway Pressure Therapy
Chest, October 1, 2004; 126(4): 1248 - 1254.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
M K Johnson, R Carter, A Nicol, R Paton, and S W Banham
Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome
Chronic Respiratory Disease, April 1, 2004; 1(2): 83 - 88.
[Abstract] [PDF]


Home page
ChestHome page
C. A. Massie and R. W. Hart
Clinical Outcomes Related to Interface Type in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome Who Are Using Continuous Positive Airway Pressure
Chest, April 1, 2003; 123(4): 1112 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. F. Fitzpatrick, C. E. D. Alloway, T. M. Wakeford, A. W. MacLean, P. W. Munt, and A. G. Day
Can Patients with Obstructive Sleep Apnea Titrate Their Own Continuous Positive Airway Pressure?
Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 716 - 722.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Rebuttal from Dr. Black
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 107 - 108.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
S. Boyer and V. Kapur
Obstructive Sleep Apnea: Its Relevance in the Care of Diabetic Patients
Clin. Diabetes, July 1, 2002; 20(3): 126 - 132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Thoracic Society